Prosecution Insights
Last updated: April 19, 2026
Application No. 17/923,448

EMULSIFIER AND EMULSION COMPOSITION CONTAINING SAME

Final Rejection §103§112§DP
Filed
Nov 04, 2022
Examiner
PIPIC, ALMA
Art Unit
1617
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Shin-Etsu Chemical Co. Ltd.
OA Round
2 (Final)
55%
Grant Probability
Moderate
3-4
OA Rounds
3y 1m
To Grant
99%
With Interview

Examiner Intelligence

Grants 55% of resolved cases
55%
Career Allow Rate
380 granted / 696 resolved
-5.4% vs TC avg
Strong +57% interview lift
Without
With
+56.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
57 currently pending
Career history
753
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
40.6%
+0.6% vs TC avg
§102
10.2%
-29.8% vs TC avg
§112
32.2%
-7.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 696 resolved cases

Office Action

§103 §112 §DP
-DETAILED ACTION- Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Applicant's response dated January 26, 2026 is acknowledged. Priority This application is a 371 of PCT/JP2021/0l 7868 filed on 05/11/2021, and claims foreign priority in Japanese application JP2020-089623 filed on 05/22/2020. Claim Status Claims 1-5 are pending. Claims 3-5 are withdrawn. Claim 1 was amended. Claims 1 and 2 are examined. Withdrawn Claim Rejections - 35 USC§ 112 Rejections of claims 1 and 2 are withdrawn because rejections were obviated with claim amendments. Withdrawn Claim Rejections – 35 USC § 103 Rejections of claims 1 and 2 over Steffen (US 2004/0209973 Al Published October 21, 2004) are withdrawn because claim 1 was amended by narrowing the scope of the variable B, which is no longer obvious over Steffen. Withdrawn Double Patenting Rejections Rejections of claims 1 and 2 are withdrawn because applicant filed a terminal disclaimer on January 26, 2026, which was approved on February 22, 2026. Terminal Disclaimer The terminal disclaimer filed on January 26, 2026 disclaiming the terminal portion of any patent granted on this application which would extend beyond the expiration date of any patent granted on application 17/923,146 has been reviewed and is accepted. The terminal disclaimer has been recorded. Maintained Claim Rejection - 35 USC§ 103 Modified as Necessitated by Amendment In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 1 and 2 are rejected under 35 U.S.C. 103 as being unpatentable over Hata (U.S. Patent No. 10,851,194 B2, Filed on February 7, 2019, Foreign Application Priority Data February 9, 2018). The claims encompass an emulsifier comprised of a diblock copolymer. The teachings of Hata are related to a methacrylic silicone graft copolymer (Abstract). In one embodiment, the copolymer comprises repeating units of formula I and II, and a structure of formula III at one terminal and a structure of formula IV at the other terminal PNG media_image1.png 425 390 media_image1.png Greyscale PNG media_image2.png 323 418 media_image2.png Greyscale (column 3 lines 15-63). The variable A is a group having a linear organopolysiloxane structure represented by the following formula (1) or a group having a dendritic organopolysiloxane structure represented by the following formula (2-1) or (2 -2): PNG media_image3.png 107 390 media_image3.png Greyscale PNG media_image4.png 84 416 media_image4.png Greyscale (from column 2 line 31 to column 3 line 15). All monomers used in the reaction are mixed in advance and added dropwise so as to obtain a random copolymer. Meanwhile, the monomers used in the reaction are alternately added in the reaction solution so as to obtain a block copolymer. For example, the monomer represented by the general formula (4) is first added dropwise to be reacted and, then, the monomer represented by the general formula (5) is added dropwise to the reaction mixture after confirming the completion of the reaction of the monomer (4) to thereby 55 obtain an AB block copolymer (column 14 lines 46-55). The number average molecular weight (Mn) of the present (meth) acrylic silicone graft (co)polymer is 1,000 to 10 1,000,000 g/mol, preferably 3,000 to 100,000 g/mol, further preferably 5,000 to 50,000 g/mol (column 15 lines 9-12). It would have been prima facie obvious to a person of ordinary skill in the art before the effective filing date of the claimed invention to have formed a di block copolymer comprising a block of repeating units of formula (I) and a block of repeating units of formula (II), a terminal group of formula (III) on one terminal and a compound of formula (IV) on the other terminal, with a reasonable expectation of success because Hata teaches a polymer having repeating units of formula I and II, and one end groups of formula III and the other end groups of formula IV, where the copolymer includes block copolymers having an AB structure. The claimed unit of formula I is obvious over Hata' s unit of formula I because RI in both encompasses a hydrogen atom and a methyl group. The claimed variable A of formula (1) overlaps with Hata's general formula (1) because both require Z to be a divalent organic group, R2 is a saturated hydrocarbon group having 1-10 carbon atoms or phenyl, R3 is is a saturated hydrocarbon group having 1-10 carbon atoms, and mis 0-100. The claimed range for nl is obvious because it overlaps with Hata' s range of 1 or larger. The claimed unit of formula II is obvious over Hata's formula II because R1 in both is a hydrogen atom or a methyl group. Hata defines the variable B as a hydroxyl group, an amino group, or a substituted or unsubstituted, monovalent hydrocarbon group which has 1 to 20 carbon atoms and may have at least one selected from -O-, -S- and - NR-, wherein R is a hydrogen atom or a monovalent hydrocarbon group having 1 to 20 carbon atoms, provided that the oxygen atom, the sulfur atom and the nitrogen atom are not adjacent to each other, which renders the claimed moiety of formula (8’) -O-CH2-CH2-N(R7)2 where R7 is alkyl having 1-4 carbon atoms obvious over Hata’s variable B when the variable is a monovalent hydrocarbon having 1-20 carbon atoms, -O-, and -NR- where R is monovalent hydrocarbon having 1-20 carbon atoms. Alternatively, Hata’s variable B renders the claimed moiety of formula (9’) obvious because it is hydrocarbon group having 3-30 carbon atoms and 1-10 moieties -O- where the -O-moieties are not adjacent. The number of carbon atoms in the hydrocarbon overlaps 1-20 and at least one -O- as taught by Hata. Additionally, in column 37 lines 15-33, Hata exemplifies polymer (18) in which the unit that repeats q number of times corresponds to formula II where B is -O-CH2CH2O-CH2CH3, which is a species of claimed formula 9’ when n3 is 1, and R3 is a hydrocarbon having 2 carbon atoms. The range of variable n2 is obvious because it overlaps with the range of 1 or greater. The claimed unit of formula III is obvious over Hata' s formula III because Hata defines R7 as an alkyl group having 1-4 carbon atoms (column 2 lines 28-29), which corresponds to instantly claimed variable R6; Hata defines R9 as a hydrogen atom or an alkyl group having 1-4 carbon atoms (column 2 lines 29-31), which corresponds to instantly claimed variable R7. The claimed unit of formula IV is obvious over Hata' s formula IV because Hata defines R10 as a hydrogen atom or a methyl group (column 2 lines 31-31), which corresponds to instantly claimed R1. Hata defines X as unit A in formula I or unit B in formula II. The molecular weight range in claim 2 is obvious because it overlap's with Hata's molecular weight range. The specification was reviewed and there is no evidence that the claimed range is critical. The intended use of the instantly claimed copolymer is an emulsifier. Hata's copolymers meet all of the structural limitations of the instantly claimed copolymers and it would have been reasonable to expect Hata's copolymers to have the same properties as instantly claimed copolymers when tested under the same conditions including having emulsifier properties. Maintained Double Patenting Rejections The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1 and 2 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-8 of U.S. Patent No. 10,851,194 B2. Although the claims at issue are not identical, they are not patentably distinct from each other because it would have been prima facie obvious to a person skilled in the art before the effective filing date of the claimed invention to have formed the copolymer in patented claims as a block copolymer, with a reasonable expectation of success because there is limited number of ways to polymerize two monomers from which repeating units I and II are derived, and all would have been equally obvious. The patented methods and products do not limit the copolymer by monomer arrangement within the polymer molecule, such as diblock, multi-block, random, or gradient. The skilled artisan would have recognized that these are the known ways to arrange the two monomers within the polymer, and any one would have been equally obvious including polymerizing the two monomers in a manner that produces a di block copolymer as instantly claimed. The patented claims do not describe the copolymer as an emulsifier, however the patented copolymer meets the structural requirements of the instantly claimed copolymer and it would have been reasonable to expect the patented copolymer have emulsifier properties. Response to Arguments Applicant’s arguments submitted in the remarks dated January 26, 2026, were fully considered but are not persuasive for the following reasons. The rejection over Hata is maintained and modified to address the definition of B as amended. Hata teaches block copolymers and the skilled artisan would have understood that a block copolymer made from two different monomers would be a diblock copolymer, thus Hata teaches diblock copolymers. Hata is not limited by exemplified embodiments, therefore Hata’s broadest teachings encompass claimed formula II. Data in the specification was reviewed, however Hata’s diblock copolymer meets all of the structural limitations of the instantly claimed diblock copolymer and it would have been reasonable to expect Hata’s copolymer to have the same beneficial properties as claimed copolymer, including having emulsifier properties. Hata is not required to teach that the diblock copolymer is an emulsifier to meet the limitation because the chemical structure of the polymer is met and it would have been reasonable to expect Hata’s copolymer have emulsifier properties. Double patenting rejections over Hata are maintained because Hata’s definition of B encompasses instantly claimed chemical structures 8’ and 9’, which renders the structures obvious. Conclusion No claims are allowed. THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Alma - Pipic whose telephone number is (571)270-7459. The examiner can normally be reached M-F 9:00am-5:00pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner's supervisor, Michael Hartley can be reached on 571-272-0616. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ALMA PIPIC/ Primary Examiner, Art Unit 1617
Read full office action

Prosecution Timeline

Nov 04, 2022
Application Filed
Oct 23, 2025
Non-Final Rejection — §103, §112, §DP
Jan 26, 2026
Response Filed
Feb 23, 2026
Final Rejection — §103, §112, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599673
TECHNIQUES FOR ENHANCING THE SELECTIVITY AND EFFICACY OF ANTIMICROBIAL AND ANTICANCER POLYMER AGENTS
2y 5m to grant Granted Apr 14, 2026
Patent 12583971
BIOSOURCED GELLING POLYAMIDES
2y 5m to grant Granted Mar 24, 2026
Patent 12557813
AGROCHEMICAL COMPOSITION OF TRIAZOLES
2y 5m to grant Granted Feb 24, 2026
Patent 12551441
Water Soluble Silicon-Containing Granulate
2y 5m to grant Granted Feb 17, 2026
Patent 12543739
UNIVERSAL PHOTODYNAMIC SPRAY COATINGS FOR INFECTION CONTROL
2y 5m to grant Granted Feb 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
55%
Grant Probability
99%
With Interview (+56.9%)
3y 1m
Median Time to Grant
Moderate
PTA Risk
Based on 696 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month